United States · Platforms & data · MarketBeat

Sagimet Biosciences (NASDAQ:SGMT) Stock Price Target Cut by Canaccord Genuity Group

Published by MarketBeat · United States 34 min ago

Image from MarketBeat Media, LLC. · MarketBeat

Detailed summary

Canaccord Genuity Group reduced their target price on shares of Sagimet Biosciences from $56.00 to $50.00 and set a "buy" rating on the stock in a research report on Friday.

Read the full article on MarketBeat Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.marketbeat.com)

Also worth reading

Seeking Alpha

Moving iMage Technologies GAAP EPS of $0.02, revenue of $6.1M

The Motley Fool

ADI Global Distribution: 3 Key Takeaways for Long-Term Investors

MarketWatch

Midterm elections provided the hyperscalers with the excuse they needed to cut back on spending, says Jefferies strategist

Yahoo Finance

U-wifi Names Charlie Vogt to its Board of Directors

TheStreet

Soon We’ll Need an Advanced AI Chip … Just to Understand the Nvidia Drama

CNBC